Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 26 results.
User Information
Export Records
  1. 1.   Sequencing-based functional assays for classification of BRCA2 variants in mouse ESCs
  2. Biswas,Kajal; Mitrophanov,Alex; Sahu,Sounak; Sullivan,Teresa; Southon,Eileen; Nousome,Darryl; Reid, Susan; Narula, Sakshi; Smolen, Julia; Sengupta, Trisha; Riedel-Topper, Maximilian; Kapoor, Medha; Babbar, Anav; Stauffer,Stacey; Cleveland, Linda; Tandon, Mayank; Malys,Tyler; Sharan,Shyam
  3. Cell Reports Methods. 2023, Nov 20; 3(11): 100628.
  1. 2.   Rare germline variants in PALB2 and BRCA2 in familial and sporadic chordoma
  2. Xia, Bing; Biswas,Kajal; Foo, Tzeh Keong; Torres, Thiago; Riedel-Topper, Maximilian; Southon,Eileen; Kang, Zhihua; Huo, Yanying; Reid,Susan; Stauffer,Stacey; Zhou,Weiyin; Zhu, Bin; Koka, Hela; Yepes, Sally; Brodie, Seth A; Jones,Kristine; Vogt,Aurelie; Zhu,Bin; Cater, Brian; Freedman, Neal D; Hicks,Belynda; Yeager, Meredith; Chanock, Stephen J; Couch, Fergus; Parry, Dilys M; Monteiro, Alvaro N; Goldstein, Alisa M; Carvalho, Marcelo A; Sharan,Shyam; Yang, Xiaohong R
  3. Human Mutation. 2022, Jun 28;
  1. 3.   A phase 1 and pharmacodynamic study of chronically-dosed, single-agent veliparib (ABT-888) in patients with BRCA1- or BRCA2-mutated cancer or platinum-refractory ovarian or triple-negative breast cancer
  2. Manzo, Julia; Puhalla, Shannon; Pahuja, Shalu; Ding, Fei; Lin, Yan; Appleman, Leonard; Tawbi, Hussein; Stoller, Ronald; Lee, James J; Diergaarde, Brenda; Kiesel, Brian F; Yu, Jing; Tan, Antoinette R; Belani, Chandra P; Chew, Helen; Garcia, Agustin A; Morgan, Robert J; Wahner Hendrickson, Andrea E; Visscher, Daniel W; Hurley, Rachel M; Kaufmann, Scott H; Swisher, Elizabeth M; Oesterreich, Steffi; Katz, Tiffany; Ji,Jay; Zhang, Yiping; Parchment, Ralph E; Chen, Alice; Duan, Wenrui; Giranda, Vincent; Shepherd, Stacie P; Ivy, S Percy; Chu, Edward; Beumer, Jan H
  3. Cancer Chemotherapy and Pharmacology. 2022, Apr 18; 89(5): 721-735.
  1. 4.   Germline variants in hereditary breast cancer genes are associated with early age at diagnosis and family history in Guatemalan breast cancer
  2. Ren, Megan; Orozco, Anali; Shao, Kang; Albanez, Anaseidy; Ortiz, Jeremy; Cao, Boyang; Wang, Lusheng; Barreda, Lilian; Alvarez, Christian S.; Garland,Lisa; Wu,Dongjing; Chung,Charles; Wang,Jiahui; Frone, Megan; Ralon, Sergio; Argueta, Victor; Orozco, Roberto; Gharzouzi, Eduardo; Dean, Michael
  3. Breast cancer research and treatment. 2021, Jul 1;
  1. 5.   Epidemiological and ES cell-based Functional Evaluation of BRCA2 Variants Identified in Families with Breast Cancer
  2. O'Sullivan,Theresa; Thirthagiri, Eswary; Chong, Chan-Eng; Stauffer,Stacey; Reid,Susan; Southon,Eileen; Hassan, Tiara; Ravichandran, Aravind; Wijaya, Eldarina; Lim, Joanna; Taib, Nur Aishah Mohd; Fadzli, Farhana; Yip, Cheng Har; Hartman, Mikael; Li, Jingmei; van Dam, Rob M; North, Susan L; Das, Ranabir; Easton, Douglas F; Biswas,Kajal; Teo, Soo-Hwang; Sharan,Shyam
  3. Human Mutation. 2021, Feb; 42(2): 200-212.
  1. 6.   Exploring role of 5hmC as potential marker of chemoresistance
  2. Kharat,Suhas; Sharan,Shyam
  3. MOLECULAR & CELLULAR ONCOLOGY. 2020, Oct 22; 7(6): 1827904.
  1. 7.   Functional evaluation of five BRCA2 unclassified variants identified in a Sri Lankan cohort with inherited cancer syndromes using a mouse embryonic stem cell-based assay
  2. Sirisena, Nirmala; Biswas,Kajal; Sullivan,Teresa; Stauffer,Stacey; Cleveland, Linda; Southon,Eileen; Dissanayake, Vajira H W; Sharan,Shyam
  3. Breast cancer research : BCR. 2020, May 11; 22(1): 43.
  1. 8.   RAD52 S346X Variant Reduces Breast Cancer Risk in BRCA2 Mutation Carriers
  2. Biswas,Kajal; Sharan,Shyam
  3. Molecular oncology. 2020, Apr 07;
  1. 9.   Mouse Ovarian Cancer Models Recapitulate the Human Tumor Microenvironment and Patient Response to Treatment
  2. Maniati, Eleni; Berlato, Chiara; Gopinathan, Ganga; Heath, Owen; Kotantaki, Panoraia; Lakhani, Anissa; McDermott, Jacqueline; Pegrum, Colin; Delaine-Smith, Robin M; Pearce, Oliver M T; Hirani, Priyanka; Joy, Joash D; Szabova,Ludmila; Perets, Ruth; Sansom, Owen J; Drapkin, Ronny; Bailey, Peter; Balkwill, Frances R
  3. Cell reports. 2020, Jan 14; 30(2): 525-540.e7.
  1. 10.   A Recurrent BRCA2 Mutation Explains the Majority of Hereditary Breast and Ovarian Cancer Syndrome Cases in Puerto Rico
  2. Diaz-Zabala, Hector J; Ortiz, Ana P; Garland, Lisa; Jones, Kristine; Perez, Cynthia M; Mora, Edna; Arroyo, Nelly; Oleksyk, Taras K; Echenique, Miguel; Matta, Jaime L; Dean, Michael; Dutil, Julie
  3. Cancers. 2018, Nov 02; 10(11): pii: E419.
  1. 11.   Survival of BRCA2-Deficient Cells Is Promoted by GIPC3, a Novel Genetic Interactor of BRCA2
  2. Ding, Xia; Philip, Subha; Martin, Betty; Pang, Yan; Burkett, Sandra; Swing, Debbie; Pamala, Chinmayi; Ritt, Daniel A; Zhou, Ming; Morrison, Deborah; Ji, Xinhua; Sharan, Shyam
  3. Genetics. 2017, Dec; 207(4): 1335-1345.
  1. 12.   RADX Promotes Genome Stability and Modulates Chemosensitivity by Regulating RAD51 at Replication Forks.
  2. Dungrawala, Huzefa; Bhat, Kamakoti P; Le Meur, Rémy; Chazin, Walter J; Ding, Xia; Sharan, Shyam; Wessel, Sarah R; Sathe, Aditya A; Zhao, Runxiang; Cortez, David
  3. Molecular cell. 2017, Aug 3; 67(3): 374-+.
  1. 13.   Next Generation Sequencing Reveals High Prevalence of BRCA1 and BRCA2 Variants of Unknown Significance in Early-Onset Breast Cancer in African American Women.
  2. Ricks-Santi, Luisel; McDonald, J Tyson; Gold, Bert; Dean, Michael; Thompson, Nicole; Abbas, Muneer; Wilson, Bradford; Kanaan, Yasmine; Naab, Tammey J; Dunston, Georgia
  3. Ethnicity & disease. 2017, Apr 20; 27(2): 169-178.
  1. 14.   Plumbagin, a naphthaquinone derivative induces apoptosis in BRCA 1/2 defective castrate resistant prostate cancer cells as well as prostate cancer stem-like cells
  2. Reshma, R. S.; Sreelatha, K. H.; Somasundaram, V.; Satheesh Kumar, S.; Nadhan, R.; Nair, R. S.; Srinivas, P.
  3. Pharmacological Research. 2016, Mar; 105: 134-45.
  1. 15.   Advances in using PARP inhibitors to treat cancer
  2. Kummar, S.; Chen, A.; Parchment, R. E.; Kinders, R. J.; Ji, J.; Tomaszewski, J. E.; Doroshow, J. H.
  3. Bmc Medicine. 2012, Mar; 10
  1. 16.   A comprehensive functional characterization of BRCA2 variants associated with Fanconi anemia using mouse ES cell-based assay
  2. Biswas, K.; Das, R.; Alter, B. P.; Kuznetsov, S. G.; Stauffer, S.; North, S. L.; Burkett, S.; Brody, L. C.; Meyer, S.; Byrd, R. A.; Sharan, S. K.
  3. Blood. 2011, Sep; 118(9): 2430-2442.
  1. 17.   Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer
  2. Gaudet, M. M.; Kirchhoff, T.; Green, T.; Vijai, J.; Korn, J. M.; Guiducci, C.; Segre, A. V.; McGee, K.; McGuffog, L.; Kartsonaki, C.; Morrison, J.; Healey, S.; Sinilnikova, O. M.; Stoppa-Lyonnet, D.; Mazoyer, S.; Gauthier-Villars, M.; Sobol, H.; Longy, M.; Frenay, M.; Hogervorst, F. B. L.; Rookus, M. A.; Collee, J. M.; Hoogerbrugge, N.; van Roozendaal, K. E. P.; Piedmonte, M.; Rubinstein, W.; Nerenstone, S.; Van Le, L.; Blank, S. V.; Caldes, T.; de la Hoya, M.; Nevanlinna, H.; Aittomaki, K.; Lazaro, C.; Blanco, I.; Arason, A.; Johannsson, O. T.; Barkardottir, R. B.; Devilee, P.; Olopade, O. I.; Neuhausen, S. L.; Wang, X. S.; Fredericksen, Z. S.; Peterlongo, P.; Manoukian, S.; Barile, M.; Viel, A.; Radice, P.; Phelan, C. M.; Narod, S.; Rennert, G.; Lejbkowicz, F.; Flugelman, A.; Andrulis, I. L.; Glendon, G.; Ozcelik, H.; Tol, A. E.; Montagna, M.; D'Andrea, E.; Friedman, E.; Laitman, Y.; Borg, A.; Beattie, M.; Ramus, S. J.; Domchek, S. M.; Nathanson, K. L.; Rebbeck, T.; Spurdle, A. B.; Chen, X. Q.; Holl, H.; John, E. M.; Hopper, J. L.; Buys, S. S.; Daly, M. B.; Southey, M. C.; Terry, M. B.; Tung, N.; Hansen, T. V. O.; Nielsen, F. C.; Greene, M. I.; Mai, P. L.; Osorio, A.; Duran, M.; Andres, R.; Benitez, J.; Weitzel, J. N.; Garber, J.; Hamann, U.; Peock, S.; Cook, M.; Oliver, C.; Frost, D.; Platte, R.; Evans, D. G.; Lalloo, F.; Eeles, R.; Izatt, L.; Walker, L.; Eason, J.; Barwell, J.; Godwin, A. K.; Schmutzler, R. K.; Wappenschmidt, B.; Engert, S.; Arnold, N.; Gadzicki, D.; Dean, M.; Gold, B.; Klein, R. J.; Couch, F. J.; Chenevix-Trench, G.; Easton, D. F.; Daly, M. J.; Antoniou, A. C.; Altshuler, D. M.; Offit, K.; kConFab, G. S. C. H. S. C. O.
  3. Plos Genetics. 2010, Oct; 6(10): 12.
  1. 18.   Family history of cancer and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan)
  2. Jacobs, E. J.; Chanock, S. J.; Fuchs, C. S.; LaCroix, A.; McWilliams, R. R.; Steplowski, E.; Stolzenberg-Solomon, R. Z.; Arslan, A. A.; Bueno-de-Mesquita, H. B.; Gross, M.; Helzlsouer, K.; Petersen, G.; Zheng, W.; Agalliu, I.; Allen, N. E.; Amundadottir, L.; Boutron-Ruault, M. C.; Buring, J. E.; Canzian, F.; Clipp, S.; Dorronsoro, M.; Gaziano, J. M.; Giovannucci, E. L.; Hankinson, S. E.; Hartge, P.; Hoover, R. N.; Hunter, D. J.; Jacobs, K. B.; Jenab, M.; Kraft, P.; Kooperberg, C.; Lynch, S. M.; Sund, M.; Mendelsohn, J. B.; Mouw, T.; Newton, C. C.; Overvad, K.; Palli, D.; Peeters, P. H. M.; Rajkovic, A.; Shu, X. O.; Thomas, G.; Tobias, G. S.; Trichopoulos, D.; Virtamo, J.; Wactawski-Wende, J.; Wolpin, B. M.; Yu, K.; Zeleniuch-Jacquotte, A.
  3. International Journal of Cancer. 2010, Sep; 127(6): 1421-1428.
  1. 19.   Functional analysis of human BRCA2 variants using a mouse embryonic stem cell-based assay
  2. Kuznetsov, S. G.; Chang, S.; Sharan, S. K.
  3. Methods in molecular biology (Clifton, N.J.). 2010 653: 259-80.
  1. 20.   Expression of human BRCA1 variants in mouse ES cells allows functional analysis of BRCA1 mutations
  2. Chang, S.; Biswas, K.; Martin, B. K.; Stauffer, S.; Sharan, S. K.
  3. Journal of Clinical Investigation. 2009, Oct; 119(10): 3160-71.
  1. 21.   Functional Redundancy of Exon 12 of BRCA2 Revealed by a Comprehensive Analysis of the c.6853A > G (p.I2285V) Variant
  2. Li, L. L.; Biswas, K.; Habib, L. A.; Kuznetsov, S. G.; Hamel, N.; Kirchhoff, T.; Wong, N.; Armel, S.; Chong, G.; Narod, S. A.; Claes, K.; Offit, K.; Robson, M. E.; Stauffer, S.; Sharan, S. K.; Foulkes, W. D.
  3. Human Mutation. 2009 30(11): 1543-1550.
  1. 22.   A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1)
  2. Thomas, G.; Jacobs, K. B.; Kraft, P.; Yeager, M.; Wacholder, S.; Cox, D. G.; Hankinson, S. E.; Hutchinson, A.; Wang, Z.; Yu, K.; Chatterjee, N.; Garcia-Closas, M.; Gonzalez-Bosquet, J.; Prokunina-Olsson, L.; Orr, N.; Willett, W. C.
  3. Nature Genetics. 2009 41(5): 579-584.
  1. 23.   C/EBP delta is a crucial regulator of pro-apoptotic gene expression during mammary gland involution
  2. Thangaraju, M.; Rudelius, M.; Bierie, B.; Raffeld, M.; Sharan, S.; Hennighausen, L.; Huang, A. M.; Sterneck, E.
  3. Development. 2005, NOV; 132(21): 4675-4685.
  1. 24.   Analysis of albumin-associated peptides and proteins from ovarian cancer patients
  2. Lowenthal, M. S.; Mehta, A. I.; Frogale, K.; Bandle, R. W.; Araujo, R. P.; Hood, B. L.; Veenstra, T. D.; Conrads, T. P.; Goldsmith, P.; Fishman, D.; Petricoin, E. F.; Liotta, L. A
  3. Clinical Chemistry. 2005, OCT; 51(10): 1933-1945.
  1. 25.   BRCA2 deficiency in mice leads to meiotic impairment and infertility
  2. Sharan, S. K.; Pyle, A.; Coppola, V.; Babus, J.; Swaminathan, S.; Benedict, J.; Swing, D.; Martin, B. K.; Tessarollo, L.; Evans, J. P.; Flaws, J. A.; H, el
  3. Development. 2004 131(1): 131-142.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel